Found: 14
Select item for more details and to access through your institution.
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetic Drug–Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 8, p. 679, doi. 10.1007/s40261-022-01179-x
- By:
- Publication type:
- Article
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 302, n. 23, p. 2557, doi. 10.1001/jama.2009.1866
- By:
- Publication type:
- Article
Erratum to: Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 110, n. 2, p. 257, doi. 10.1007/s11060-012-0964-7
- By:
- Publication type:
- Article
The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 5, p. 375, doi. 10.1007/s00280-002-0424-8
- By:
- Publication type:
- Article
Ethylene glycol toxicity associated with ischemia, perforation, and colonic oxalate crystal deposition.
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month international multi-center phase 3 trial
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Effect of Hepatic Impairment on Trilaciclib Pharmacokinetics.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 8, p. 975, doi. 10.1002/jcph.2435
- By:
- Publication type:
- Article
Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 6, p. 858, doi. 10.1111/bcp.12160
- By:
- Publication type:
- Article
Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 4, p. 421, doi. 10.1111/j.1365-2125.2009.03370.x
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure–response of trilaciclib in extensive‐stage small cell lung cancer and triple‐negative breast cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 3, p. 1067, doi. 10.1111/bcp.15549
- By:
- Publication type:
- Article
Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2017, v. 97, n. 3, p. 702, doi. 10.4269/ajtmh.16-0779
- By:
- Publication type:
- Article